management of persistent hypoxemic respiratory failure in the icu garpestad

83
Management of Persistent Hypoxemic Respiratory Failure in the ICU Erik Garpestad, M.D. Director, MICU Tufts Medical Center

Upload: dang-thanh-tuan

Post on 07-May-2015

4.760 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Page 1: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Management of Persistent Hypoxemic Respiratory Failure

in the ICU

Erik Garpestad, M.D.

Director, MICU

Tufts Medical Center

Page 2: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Case Presentation

• 73 yo male underwent elective laporscopic surgery for lyses of abdominal adhesions.

• Surgery went well, pt extubated post-op without difficulty.

• POD# 1 pt developed abdominal pain, fever, hypotension requiring reoperation for peritonitis related to bowel perforation

Page 3: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Case: persistent hypoxia

• For septic shock, pt started on EGDT, 3 pressor agents, VC ventilation with 6 ml/kg of IBW, PEEP 10 cm H20, FiO2 of 100%

• ABG 7.10/46/53

• RR increase, PEEP increased 15-18 cm H20 but ABG with minimal improvement

Page 4: Management of persistent hypoxemic respiratory failure in the icu   garpestad
Page 5: Management of persistent hypoxemic respiratory failure in the icu   garpestad
Page 6: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Persistent Hypoxemia

• What are your options?

• How do you balance need to improve oxygen exchange and optimize oxygen delivery vs lung protective strategy

• These goals are not mutually exclusive

Page 7: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Persistent Hypoxemia

• Increase FiO2, increase PEEP• Recruitment maneuvers• Prone positioning• NO• Ventilator strategies: Lung protective and Open

lung approach• APRV• HFOV

Page 8: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Benefits of Mechanical Ventilation

• Improved oxygenation

• Decreased work of breathing

Page 9: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Risks of Mechanical Ventilation

• Barotrauma

• Biotrauma

• Baby lung

• Cyclic atelectasis

Page 10: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Minimizing MV Risks

• What pressures to measure?

• What modality to use?

• Is there a safe PIP?

• Is there a safe plateau pressure?

• How do you set optimal PEEP?

Page 11: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Ventilator Strategy

• Low tidal volume strategy

• Open lung strategy

Page 12: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Other Ventilator Strategies

• APRV

• HFOV

• TGI

• ECMO

Page 13: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Discussion

• What do you do to decrease risks?

Page 14: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Ware, L. B. et al. N Engl J Med 2000;342:1334-1349

Radiographic and Computed Tomographic (CT) Findings in the Acute, or Exudative, Phase (Panels A and C) and the Fibrosing-Alveolitis Phase (Panels B and D) of Acute Lung Injury

and the Acute Respiratory Distress Syndrome

Page 15: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: Mechanical Ventilation

• Traditional approach:– Normalize blood gases– High minute ventilation– High tidal volumes– High inflation pressures

Page 16: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: Mechanical Ventilation

• Maintain adequate oxygenation (PaO2 of 55-80 mmHg or SaO2 of 88-95%

• Avoid oxygen toxicity

• Employ PEEP

• Prevent ventilator induce lung injury

• Minimize barotrauma and volutrauma

Page 17: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Ventilator Induced Lung Injury

• Volutrauma:– Overdistention, physical injury– Biotrauma

• Atelectrauma:– Repetitive opening/closing– Shear forces at open/collapse lung interface

Page 18: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Barotrauma

Page 19: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Tobin, M. J. N Engl J Med 2001;344:1986-1996

Lung Injury Caused by Mechanical Ventilation in a 31-Year-Old Woman with the Acute Respiratory Distress Syndrome Due to Amniotic-Fluid Embolism

Page 20: Management of persistent hypoxemic respiratory failure in the icu   garpestad
Page 21: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Tobin, M. J. N Engl J Med 2001;344:1986-1996

Respiratory Pressure-Volume Curve and the Effects of Traditional as Compared with Protective Ventilation in a 70-kg Patient with the Acute Respiratory Distress Syndrome

Page 22: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: ARDS Network Trial

• Largest randomized trial to date

• Compared traditional mechanical ventilation (15 ml/kg, plateau < 50 cm H2O) to lower tidal volume (6 ml/kg, plateau < 30 cm H20)

• Trial stopped after 861 pts because mortality was lower in low Vt pts, 31% vs 39.8%, p=0.007 (NEJM 2000;342:1301)

Page 23: Management of persistent hypoxemic respiratory failure in the icu   garpestad

The Acute Respiratory Distress Syndrome Network, N Engl J Med 2000;342:1301-1308

Summary of Ventilator Procedures

Page 24: Management of persistent hypoxemic respiratory failure in the icu   garpestad

The Acute Respiratory Distress Syndrome Network, N Engl J Med 2000;342:1301-1308

Main Outcome Variables

Page 25: Management of persistent hypoxemic respiratory failure in the icu   garpestad

The Acute Respiratory Distress Syndrome Network, N Engl J Med 2000;342:1301-1308

Probability of Survival and of Being Discharged Home and Breathing without Assistance during the First 180 Days after Randomization in Patients with Acute Lung Injury and the

Acute Respiratory Distress Syndrome

Page 26: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: Mechanical Ventilation

• What mode of ventilation to use?– Either volume cycled ventilation or pressure

cycled ventilation can be used– Choosing appropriate goals for mechanical

ventilation is more important than mode– Target Vt of 6 ml/kg and plateau pressure less

than 30 cm H2O

Page 27: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: Mechanical Ventilation

• After starting at Vt of 6 ml/kg and keeping plateau pressures < 30 cm H2O:– adjust PEEP. Can use ARDSNet protocol– if FiO2 > 0.6, lengthen inspiratory time or

consider IRV– adequate sedation if permissive hypercapnea is

a consequence of ventilatory strategy

Page 28: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: Mechanical Ventilation

• ARDSnet established the benefit of small tidal volumes (4-8 ml/kg predicted ideal body weight) ventilation on ALI/ARDS mortality

• Active debate continues over level of PEEP and the use of recruitment maneuvers

Page 29: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: PEEP

• Improves oxygenation

• Recruits atelectatic lung and prevents alveolar collapse

• Increases FRC

• Improves lung compliance

• Assists in minimizing VILI

Page 30: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Pressure Volume Curve in ARDS

LIP

Volume

Pressure

UIP

1

2

3

1 2 3

1

2

3

1

2

3

Too much VT

Too littlePEEP

Page 31: Management of persistent hypoxemic respiratory failure in the icu   garpestad

PEEP 5

PEEP 10 PEEP 15PEEP 5

By keeping intrathoracic pressure positive throughoutthe respiratory cycle atelectatic lung can be re-expandedor recruited. Shunt decreases and PaO2 increases.

PaO2 = 60 PaO2 = 100 PaO2 = 220

Page 32: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: What is optimal level of PEEP?

• Amato et al (NEJM 1998) used an “open-lung” strategy. PEEP (1st 36 hrs) in conventional ventilation was 8.7 and in protective ventilation was 16.4 cm H2O.

• Mortality difference 72% vs 38%

• However, patients who received higher PEEP levels also received lower Vt.

Page 33: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Amato M et al. N Engl J Med 1998;338:347-354

Actuarial 28-Day Survival among 53 Patients with the Acute Respiratory Distress Syndrome Assigned to Protective or Conventional Mechanical Ventilation

Page 34: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: What is optimal level of PEEP?

• NIH ARDS Clinical Trials Network looked at Higher vs Lower PEEP in ARDS patients

• 549 pts with ALI or ARDS randomly assigned to low PEEP (mean on day 1-4 was 8.3 + 3.2 cm H2O) vs high PEEP (mean 13.2 + 3.5 cm H2O)

• No significant difference in mortality, vent free days, ICU-free days or Organ failure.

Page 35: Management of persistent hypoxemic respiratory failure in the icu   garpestad

The National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. N Engl J Med 2004;351:327-336

Summary of Ventilator Procedures in the Lower- and Higher-PEEP Groups

Page 36: Management of persistent hypoxemic respiratory failure in the icu   garpestad

The National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. N Engl J Med 2004;351:327-336

Probabilities of Survival and of Discharge Home While Breathing without Assistance, from the Day of Randomization (Day 0) to Day 60 among Patients with Acute Lung Injury and ARDS,

According to Whether Patients Received Lower or Higher Levels of PEEP

Page 37: Management of persistent hypoxemic respiratory failure in the icu   garpestad

The National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. N Engl J Med 2004;351:327-336

Main Outcome Variables

Page 38: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDSnet High/Low PEEP trial

Potential Concerns:

• Plateau pressures in both groups not dangerously high and importance of PEEP is likely to depend on plateau pressure

• Baseline imbalances in age at randomization

• Recruitment maneuvers not used

Page 39: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: Recruitment maneuvers

• Strategy of using a sustained, high pressure breath to recruit or open atelectatic lung

• No standard method. For example: Sustain single inflation at CPAP of 35 cm H2O for 60 seconds. Monitor SaO2 and BP

• Need to use higher PEEP after maneuver: go to 20 cm H2O and then decrease sequentially by 2.5 cm until dec SaO2

Page 40: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Borges J et al. N Engl J Med 2006;355:319-322

Computed Tomographic Images Obtained at the End-Expiratory Pause in a Patient with Pneumocystosis and the Acute Respiratory Distress Syndrome

Page 41: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Gattinoni L et al. N Engl J Med 2006;354:1775-1786

Enrollment and Study Protocol

Page 42: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Gattinoni L et al. N Engl J Med 2006;354:1775-1786

Frequency Distribution of Patients According to the Percentage of Potentially Recruitable Lung (Panel A) and CT Images at Airway Pressures of 5 and 45 cm of Water from Patients with a Lower

Percentage of Potentially Recruitable Lung (Panel B) and Those with a Higher Percentage of Potentially Recruitable Lung (Panel C)

Page 43: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: Open Lung Approach

• To determine if the use of lung recruitment maneuvers and a decremental PEEP trial along with small Vt results in lower mortality in severe established ARDS than the original ARDSnet protocol

Page 44: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: Open Lung Approach

• Intubated, ventilated, ARDS criteria met

• Initial 12-36 hrs, pts will be ventilated per ARDSnet protocol

• Reassessment of oxygenation, PaO2/FiO2 still <200 for pt to be randomized

• Pts randomized to ARDSnet protocol and Open Lung Approach

Page 45: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: Open Lung Approach

• Lung recruitment procedure:– PEEP 25 cm H2O, PCV 15 cm H2O (Peak

airway pressure 40 cm H2O) for 5 breaths– PEEP 25, PCV 20 for 5 breaths– PEEP 30, PCV 20 for final 20 breaths

• Decremental PEEP procedure: decrease in 2 cm H2O steps until the maximum compliance is identified

Page 46: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: Permissive Hypercapnia

• Allowing respiratory acidosis improves our ability to use lower tidal volumes and airway pressures

• May require sedation, or even paralysis

• Contraindicated in pts with increased ICP

Page 47: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: Inverse Ratio Ventilation

• Increase I:E ratio from 1:3 to 1:1 or more

• Increasing inspiratory time improves oxygenation without increasing pressures

• Watch for dynamic hyperinflation or worsening hemodynamics

Page 48: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: Prone positioning

• Improves oxygenation but no change in mortality (NEJM 2001;345:568)

• Not routinely recommended

• Consider use early in course of ALI/ARDS in patients requiring high PEEP and FiO2.

• Try recruitment maneuvers first

Page 49: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Supine Prone

Dependent Atelectasis

Page 50: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: Supportive Care

• Fluid management– maintain intravascular volume at lowest level

that allows for adequate perfusion

• Nutrition– enteral feedings when possible

• Prophylaxis– for DVT and GI bleeding

Page 51: Management of persistent hypoxemic respiratory failure in the icu   garpestad

The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. N Engl J Med 2006;354:2213-2224

Kaplan-Meier Estimates of the Probability of Survival and of Survival without the Need for Assisted Ventilation during the First 60 Days after Randomization

Page 52: Management of persistent hypoxemic respiratory failure in the icu   garpestad

The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. N Engl J Med 2006;354:2564-2575

Probability of Survival to Hospital Discharge and of Breathing without Assistance during the First 60 Days after Randomization

Page 53: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: Pharmacological Therapy

• Antibiotics

• Neuromuscular blockade

Page 54: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: Pharmacological Therapy

• Corticosteroids– No benefit early in course of ALI/ARDS– Have been used in fibrosing-alveolitis phase of

ARDS– Consider short course in pts with severe disease

that have prolonged course and not improving (Meduri, JAMA 1998;280:159)

Page 55: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS: Pharmacological Therapy

• Inhaled nitric oxide– may improve oxygenation and PVR, but only

transiently. No improvement in outcome

• Inhaled surfactant– no outcome improvement

Page 56: Management of persistent hypoxemic respiratory failure in the icu   garpestad

ARDS

• Mechanical Ventilation of 6 ml/kg and maintain plateau < 30 cm H20

• Lowest FiO2 that maintains adequate oxygenation

• Titrate PEEP

• Supportive care

Page 57: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Alternative Methods of Ventilatory Support

• Airway pressure release ventilation

• High-Frequency Ventilation

Page 58: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Case presentation

• 73 yo male underwent elective laporscopic surgery for lysis of abdominal adhesions.

• Surgery went well, pt extubated post-op without difficulty.

• POD# 1 pt developed abdominal pain, fever, hypotension requiring reoperation for peritonitis related to bowel perforation

Page 59: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Case: persistent hypoxia

• For septic shock, pt started on EGDT, 3 pressor agents, VC ventilation with 6 ml/kg IBW, PEEP 10 cm H20, FiO2 of 100%

• ABG 7.10/46/53

• RR increase, PEEP increased 15-18 cm H20 but ABG with minimal improvement

Page 60: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Case: Persistent hypoxemia

• Inhaled NO was started

• APRV: Hi-PEEP 32, low-PEEP 15, FiO2 of 100%. ABG 7.24/32/63

• HFOV: Mean airway pressure 32, frequency 5 Hz, set oscillation pressure for “Movement of torso from clavicle to mid thigh”. ABG 7.23/31/65

Page 61: Management of persistent hypoxemic respiratory failure in the icu   garpestad

What is APRV?

• An “open” ventilator strategy

• Essentially = CPAP + Time Cycled Pressure Release

Habashi NM, crit care med 2005: 33(3S)

Page 62: Management of persistent hypoxemic respiratory failure in the icu   garpestad

APRV Pressure/Flow Diagram

Page 63: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Theoretical Advantages

• Spontaneous Breathing Allows:– Improved Ventilation of Dependent Lung– Less Likely to have alveolar overdistention– Potentially less sedation

• Increased time at high pressures may improve recruitment

Page 64: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Theoretical Advantages

• Pressure Release– Improved TV for given ΔP, utilizes increased

elastic recoil, expiratory limb of PV curve– Less chance of over distension given not

“filling” lung but “emptying”.– Short release time does not allow significant

dercruitment

Page 65: Management of persistent hypoxemic respiratory failure in the icu   garpestad

APRV Settings

• Phigh = CPAP

• Plow = Release Pressure

• Thigh = Time at Phigh

• Tlow = Time at Plow

• Can supplement spontaneous breathing with pressure support

Page 66: Management of persistent hypoxemic respiratory failure in the icu   garpestad

APRV Settings

• Phigh

– Newly Intubated = Desired Pplat– From Conventional Vent = Current Pplat

• Plow

– Suggested setting: 0

• Thigh

– 4-6 secs

• Tlow

– 0.2-0.8 secs

Habashi NM, crit care med 2005: 33(3S)

Page 67: Management of persistent hypoxemic respiratory failure in the icu   garpestad

APRV Settings

• Oxygenation– Decrease Tlow to ensure end-exhaled flow rate is

>50% PEFR and < 75% PEFR– Increase Phigh and/or Thigh

• Ventilation– Assess sedation– Increase Phigh and/or Thigh ( TV)– Decrease Thigh ( Ve)

Habashi NM, crit care med 2005: 33(3S)

Page 68: Management of persistent hypoxemic respiratory failure in the icu   garpestad

APRV Pressure/Flow Diagram

Page 69: Management of persistent hypoxemic respiratory failure in the icu   garpestad

High Frequency Ventilation Modes

From UptoDate, Ostenholzer and Hyzy

Page 70: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Physiology

• Oscillating pressure around a set mean airway pressure

• Higher Mean Pressures increase oxygenation

• Lower peak pressures and in theory small volumes result in no overdistension

From Quissell et al

Page 71: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Increased Mean Pressures = Improved oxygenation

From Mehta et al Critical Care 2001

Page 72: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Ventilation

• Occurs through multiple proposed mechanisms– Direct Conductive– Longitudinal dispersion from turbulence– Pendeluft flow due to varying time constants– Venturi Effect– Diffusion

Page 73: Management of persistent hypoxemic respiratory failure in the icu   garpestad

From UptoDate, Ostenholzer and Hyzy

Gas Transport in HFOV

Page 74: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Case Presentation

• Pt is a 38 year-old man who presents with severe pneumonia and ARDS. The pt is started on conventional ventilation by ARDSnet protocol. Yet despite increasing PEEP to 18, the PaO2 is still 55 on an FiO2 of 1.0 – You are asked to initiate HFOV. What are your

initial settings?

Page 75: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Initial Settings

• Set Mean Pressure at Mean pressure of Conventional Ventilation

• Set Frequency 3-5 Hz

• Set oscillation pressure for “Movement of torso from clavicle to mid thigh”

Page 76: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Case Presentation

• The pt is sedated/paralyzed and placed on HFOV. Mean pressure: 25cmH2O,Frequency 3Hz and FiO2 = 1.0 Initial ABG: – pH = 7.22

– PaCO2 = 60

– PaO2 = 65

– What adjustments would you make to your settings?

Page 77: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Adjustments

• Oxygenation– Mean Pressure– FiO2

• Ventilation (CO2)– Frequency– Oscillation pressure amplitude– Intentional cuff leak

Page 78: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Case

• The frequency is increased to 5Hz and Mean pressure increased to 28cmH2O

ABG: pH = 7.30 PaCO2 = 50 PaO2 = 105

• What complications are associated with HFOV?

Page 79: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Complications

• Similar to conventional ventilation

• Higher Mean Airway Pressures may have more hemodynamic effects

• 90% + pts require paralysis – no rates of post-paralytic syndrome reported in clinical trials

Page 80: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Literature

• Neonates: associated with improved gas exchange and decreased barotrauma. No change in mortality

• Adults: Improved early oxygenation but no other outcome improved

• Can be combined with other modalities to improve oxygenation: Prone, NO

Page 81: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Randomized Trials

• Derdak et al, AJRCCM 2002: Primary outcome safety; No difference in safety c/w conventional ventilation– Mortality secondary outcome

• 37%(HFOV) vs 52% (conv) p=0.10

• Prior to ARDSnet protocol

• Bollen et al; Crit Care 2005: No mortality difference [28% vs 32%]

Page 82: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Demory et al Crit Care Med 2007

Preventing Derecruitment after Proning

Page 83: Management of persistent hypoxemic respiratory failure in the icu   garpestad

Management of Hypoxic Respiratory Failure: Conclusions

Initially employ a lung protective strategy with low tidal volumes with adequate PEEP and monitoring of plateau pressures

Routine use of Open lung approach, high PEEP, recruitment maneuvers, APRV and HFOV continue to be investigated. Select these interventions on case by case basis